12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Wednesday's intraday session, several healthcare stocks experienced significant movements. Apellis Pharmaceuticals, Aditxt, ITeos Therapeutics, RVL Pharmaceuticals, Bullfrog AI Hldgs, and Arcus Biosciences saw their shares rise by 30.2%, 29.82%, 26.63%, 26.35%, 22.49%, and 21.5% respectively. On the other hand, Longeveron Inc. - Subscription Right, GRI Bio, Mallinckrodt, Lucy Scientific Discovery, Axcella Health, and Jin Medical International saw their shares fall by 33.3%, 23.14%, 20.94%, 16.72%, 16.67%, and 15.89% respectively.
August 23, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aditxt stock increased by 29.82% to $12.99 during Wednesday's regular session.
The substantial increase in Aditxt's stock price suggests strong investor confidence in the company, potentially leading to further short-term increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Apellis Pharmaceuticals shares rose 30.2% to $40.05 during Wednesday's regular session.
The significant rise in Apellis Pharmaceuticals' share price indicates positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Bullfrog AI Hldgs shares increased by 22.49% to $3.54 during Wednesday's regular session.
The significant rise in Bullfrog AI Hldgs' share price indicates positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ITeos Therapeutics shares moved upwards by 26.63% to $14.88 during Wednesday's regular session.
The significant rise in ITeos Therapeutics' share price indicates positive market sentiment towards the company, which could lead to further short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Arcus Biosciences shares increased by 21.5% to $22.86 during Wednesday's regular session.
The substantial increase in Arcus Biosciences' stock price suggests strong investor confidence in the company, potentially leading to further short-term increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
RVL Pharmaceuticals shares increased by 26.35% to $0.18 during Wednesday's regular session.
The substantial increase in RVL Pharmaceuticals' stock price suggests strong investor confidence in the company, potentially leading to further short-term increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Axcella Health shares declined by 16.67% to $0.14 during Wednesday's regular session.
The significant drop in Axcella Health's share price indicates negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
GRI Bio stock declined by 23.14% to $2.06 during Wednesday's regular session.
The substantial decrease in GRI Bio's stock price suggests a lack of investor confidence in the company, potentially leading to further short-term decreases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Longeveron Inc. - Subscription Right stock fell 33.3% to $0.05 during Wednesday's regular session.
The significant drop in Longeveron Inc. - Subscription Right's stock price indicates negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Lucy Scientific Discovery shares fell 16.72% to $0.57 during Wednesday's regular session.
The substantial decrease in Lucy Scientific Discovery's stock price suggests a lack of investor confidence in the company, potentially leading to further short-term decreases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt shares declined by 20.94% to $0.46 during Wednesday's regular session.
The significant drop in Mallinckrodt's share price indicates negative market sentiment towards the company, which could lead to further short-term losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jin Medical International stock fell 15.89% to $11.44 during Wednesday's regular session.
The substantial decrease in Jin Medical International's stock price suggests a lack of investor confidence in the company, potentially leading to further short-term decreases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100